KILLA ACNE EXTRA STRENGTH- salicylic acid patch

দেশ: মার্কিন যুক্তরাষ্ট্র

ভাষা: ইংরেজি

সূত্র: NLM (National Library of Medicine)

সক্রিয় উপাদান:

Salicylic Acid 2%

থেকে পাওয়া:

Zitsticka, Inc.

প্রশাসন রুট:

TOPICAL

প্রেসক্রিপশন টাইপ:

OTC DRUG

থেরাপিউটিক ইঙ্গিত:

Acne Treatment Uses: - For the management of acne. - Penetrates pores to eliminate most blemishes

অনুমোদন অবস্থা:

OTC monograph final

পণ্য বৈশিষ্ট্য

KILLA ACNE EXTRA STRENGTH- SALICYLIC ACID PATCH
ZITSTICKA, INC.
_Disclaimer: Most OTC drugs are not reviewed and approved by FDA,
however they may_
_be marketed if they comply with applicable regulations and policies.
FDA has not_
_evaluated whether this product complies._
----------
ACTIVE INGREDIENTS
Salicylic Acid 2%
PURPOSE
Acne Treatment
ASK A DOCTOR
If irritation becomes severe
WHEN USING THIS PRODUCT
Skin irritation and dryness may occur if you use another topical acne
medication at the
same time or immediately following. If irritation occurs, only use one
topical acne
medication at a time unless directed by a doctor.
KEEP OUT OF REACH OF CHILDREN
If swallowed, get medical help or contact a Posion Control Center
right away.
NA
NA
WARNINGS
For extrernal use only
INACTIVE INGREDIENTS
Inactive Ingredients:
Sodium Hyaluronate, Phytosphingosine HCL, Niacinamide,
Oligopeptide-10, Glycolic Acid,
Madecassoside, 4-Butylresorcinol.
Patch: Hydrocolloid
USES
Uses:
For the management of acne.
Penetrates pores to eliminate most blemishes
KILLA ACNE ES PDP
KILLA ACNE EXTRA STRENGTH
salicylic acid patch
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN OTC DRUG
ITEM CODE (SOURCE)
NDC:81746-420
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF
STRENGTH
STRENGTH
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID -
UNII:O414PZ 4LPZ )
SALICYLIC ACID
0.0125 mg
in 0.6216 mg
INACTIVE INGREDIENTS
INGREDIENT NAME
STRENGTH
OLIGOPEPTIDE-10 (UNII: Q46328TRNK)
NIACINAMIDE (UNII: 25X51I8RD4)
GLYCOLIC ACID (UNII: 0WT12SX38S)
4-BUTYLRESORCINOL (UNII: 2IK4UQ3ZGA)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
MADECASSOSIDE (UNII: CQ2F5O6YIY)
PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU)
PACKAGING
#
ITEM
CODE
PACKAGE DESCRIPTION
MARKETING
START DATE
MARKETING
END DATE
1
NDC:81746-
420-01
3220 mg in 1 BOX; Type 2: Prefilled Drug Delivery
Device/System (syringe, patch, etc.)
05/26/2023
MARKETING INFORMATION
MARKETING
CATEGORY
APPLICATION NUMBER OR MONOGRAPH
CITATION
MARKETING START
DATE
MARKETING END
DATE
OTC monograph